Cytosorbents Operating Cycle from 2010 to 2026
| CTSO Stock | USD 0.67 0 0.30% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 195.9 | Current Value 186.1 | Quarterly Volatility 3.3 K |
Check Cytosorbents Crp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cytosorbents Crp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 M, Interest Expense of 797 K or Selling General Administrative of 42.3 M, as well as many indicators such as Price To Sales Ratio of 1.52, Dividend Yield of 0.002 or PTB Ratio of 4.21. Cytosorbents financial statements analysis is a perfect complement when working with Cytosorbents Crp Valuation or Volatility modules.
Cytosorbents | Operating Cycle | Build AI portfolio with Cytosorbents Stock |
Evaluating Cytosorbents Crp's Operating Cycle across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Cytosorbents Crp's fundamental strength.
Latest Cytosorbents Crp's Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of Cytosorbents Crp over the last few years. It is Cytosorbents Crp's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cytosorbents Crp's overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
Cytosorbents Operating Cycle Regression Statistics
| Arithmetic Mean | 1,011 | |
| Geometric Mean | 227.42 | |
| Coefficient Of Variation | 325.17 | |
| Mean Deviation | 1,498 | |
| Median | 186.10 | |
| Standard Deviation | 3,286 | |
| Sample Variance | 10.8M | |
| Range | 13.7K | |
| R-Value | (0.37) | |
| Mean Square Error | 9.9M | |
| R-Squared | 0.14 | |
| Significance | 0.14 | |
| Slope | (241.49) | |
| Total Sum of Squares | 172.8M |
Cytosorbents Operating Cycle History
About Cytosorbents Crp Financial Statements
Cytosorbents Crp investors utilize fundamental indicators, such as Operating Cycle, to predict how Cytosorbents Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 195.90 | 186.10 |
Pair Trading with Cytosorbents Crp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cytosorbents Crp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytosorbents Crp will appreciate offsetting losses from the drop in the long position's value.Moving against Cytosorbents Stock
The ability to find closely correlated positions to Cytosorbents Crp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cytosorbents Crp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cytosorbents Crp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cytosorbents Crp to buy it.
The correlation of Cytosorbents Crp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cytosorbents Crp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cytosorbents Crp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cytosorbents Crp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Cytosorbents Crp Correlation against competitors. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Will Health Care Equipment & Supplies sector continue expanding? Could Cytosorbents diversify its offerings? Factors like these will boost the valuation of Cytosorbents Crp. Projected growth potential of Cytosorbents fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cytosorbents Crp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.18) | Revenue Per Share | Quarterly Revenue Growth 0.101 | Return On Assets | Return On Equity |
Investors evaluate Cytosorbents Crp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Cytosorbents Crp's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Cytosorbents Crp's market price to deviate significantly from intrinsic value.
It's important to distinguish between Cytosorbents Crp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cytosorbents Crp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Cytosorbents Crp's market price signifies the transaction level at which participants voluntarily complete trades.